Akin Akinc
- Molecular Biology top 0.5%
- RNA Interference and Gene Delivery 31
- Advanced biosensing and bioanalysis techniques 28
- Cancer-related gene regulation 8
- Lipid Membrane Structure and Behavior 4
- Biomaterials top 0.5%
- Cancer Research top 1%
- MicroRNA in disease regulation 12
- Genetics top 1%
- Virus-based gene therapy research 6
- Immunology top 2%
-
- Hemophilia Treatment and Research 8
- Blood Coagulation and Thrombosis Mechanisms 5
- Co-authors
- Róbert LangerDaniel G. AndersonAlexander M. KlibanovMini ThomasMartin A. MaierMuthiah ManoharanKevin FitzgeraldMuthusamy Jayaraman
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Akin Akinc
52 papers receiving 9.8k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Molecular Biology 8.2k
- Biomaterials 1.4k
- Cancer Research 1.5k
- Genetics 1.5k
- Immunology 1.0k
Countries citing papers authored by Akin Akinc
This map shows the geographic impact of Akin Akinc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akin Akinc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akin Akinc more than expected).
Fields of papers citing papers by Akin Akinc
This network shows the impact of papers produced by Akin Akinc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akin Akinc. The network helps show where Akin Akinc may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akin Akinc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 17 | |
| 2 | The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugsbreakdown → | 2019 | 1160 |
| 3 | 2018 | 69 | |
| 4 | 2018 | 32 | |
| 5 | 2017 | 6 | |
| 6 | 2016 | 22 | |
| 7 | 2015 | 59 | |
| 8 | 2015 | 9 | |
| 9 | 2014 | 9 | |
| 10 | Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escapebreakdown → | 2013 | 1232 |
| 11 | 2012 | 38 | |
| 12 | Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**breakdown → | 2012 | 973 |
| 13 | MicroRNAs 103 and 107 regulate insulin sensitivitybreakdown → | 2011 | 842 |
| 14 | 2011 | 154 | |
| 15 | 2010 | 73 | |
| 16 | 2008 | 19 | |
| 17 | 2008 | 124 | |
| 18 | 2007 | 111 | |
| 19 | 2004 | 300 | |
| 20 | 2002 | 123 |
About Akin Akinc
Akin Akinc is a scholar working on Hematology, Cancer Research, Molecular Biology, Genetics and Genetics, having authored 52 papers that have together received 9.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (31 papers), Advanced biosensing and bioanalysis techniques (28 papers), MicroRNA in disease regulation (12 papers), Hemophilia Treatment and Research (8 papers), Cancer-related gene regulation (8 papers), Virus-based gene therapy research (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Lipid Membrane Structure and Behavior (4 papers). The work is most often cited by research in Molecular Biology (8.2k citations), Biomaterials (1.4k citations), Cancer Research (1.5k citations), Genetics (1.5k citations) and Immunology (1.0k citations). Akin Akinc has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Róbert Langer, Daniel G. Anderson, Alexander M. Klibanov, Mini Thomas, Martin A. Maier, Muthiah Manoharan, Kevin Fitzgerald, Muthusamy Jayaraman, Ying K. Tam and Michael J. Hope. Their work appears in journals such as Blood, Molecular Therapy, Biotechnology and Bioengineering, Nature and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.